EV/EBITDA
-0.32
+0.01+3.03%
3 min ago
Summary
- As of March 3, 2025, SLXN EV/EBITDA is -0.32, with a rise of +0.01 (+3.03%) during the most recent trading day.
- SLXN EV/EBITDA is now -3300.00% below its all-time high of 0.01.
Performance
SLXN EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
SLXN EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | +3.0% | -2.7% | -6.3% |
| 1 m1 month | +17.9% | -18.3% | -35.0% |
| 3 m3 months | +42.9% | -42.1% | -63.6% |
| 6 m6 months | -14.3% | +13.4% | -5.5% |
| ytdytd | +28.9% | -28.0% | -48.3% |
| 1 y1 year | - | - | -90.6% |
| 5 y5 years | - | - | - |
SLXN EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -10.3% | -0.47 | +31.9% | |
| 3 m | 3-month | -0.22 | -45.5% | -0.64 | +50.0% |
| 6 m | 6-month | 0.00 | <-9999.0% | -0.64 | +50.0% |
| 1 y | 1-year | 0.01 | -3300.0% | -1.85 | +82.7% |
| 3 y | 3-year | 0.01 | -3300.0% | -1.85 | +82.7% |
| 5 y | 5-year | 0.01 | -3300.0% | -1.85 | +82.7% |
| alltime | all time | 0.01 | -3300.0% | -1.85 | +82.7% |
Silexion Therapeutics LTD EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -0.32(-28.9%) |
| Date | Value |
|---|---|
| 2024 | -0.45 |
FAQ
- What is Silexion Therapeutics LTD EV/EBITDA?
- What is the all time high EV/EBITDA for Silexion Therapeutics LTD?
- What is SLXN EV/EBITDA year-to-date change?
What is Silexion Therapeutics LTD EV/EBITDA?
The current EV/EBITDA of SLXN is -0.32
What is the all time high EV/EBITDA for Silexion Therapeutics LTD?
Silexion Therapeutics LTD all-time high EV/EBITDA is 0.01
What is SLXN EV/EBITDA year-to-date change?
Silexion Therapeutics LTD EV/EBITDA has changed by +0.13 (+28.89%) since the beginning of the year